Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders
Overview
Authors
Affiliations
Hairy cell leukemia (HCL) is characterized by abnormal villous lymphoid cells that express CD103, CD123, CD25 and CD11c. HCL-like disorders, including hairy cell leukemia variant (vHCL) and splenic diffuse red pulp lymphoma (SDRPL), have similar morphologic criteria and a distinct phenotypic and genetic profile. We investigated the immunophenotypic features of a large cohort of 82 patients: 68 classical HCL, 5 vHCL/SDRPL and 9 HCL-like NOS. The HCL immunophenotype was heterogeneous: positive CD5 expression in 7/68 (10%), CD10 in 12/68 (18%), CD38 in 24/67 (36%), CD23 in 22/68 (32%) and CD43 in 19/65 (31%) patients. CD26 was expressed in 35/36 (97%) of HCL patients, none of vHCL/SDRPL and one of seven HCL-like NOS (14%). When adding CD26 to the immunologic HCL scoring system (one point for CD103, CD123, CD25, CD11c and CD26), the specificity was improved, increasing from 78.6% to 100%. We used unsupervised analysis of flow cytometry raw data (median fluorescence, percentage of expression) and the mutational profile of and . The analysis showed good separation between HCL and vHCL/SDRPL. The HCL score is not sufficient, and the use of unsupervised analysis could be promising to achieve a distinction between HCL and HCL-like disorders. However, these preliminary results have to be confirmed in a further study with a higher number of patients.
Splenic B-cell Lymphoma / Leukemia with Prominent Nucleoli.
Gupta L, Chopra A Indian J Hematol Blood Transfus. 2025; 41(1):213-214.
PMID: 39917512 PMC: 11794748. DOI: 10.1007/s12288-024-01795-x.
Pure Biclonal Hairy Cell Leukemia-Apt Diagnosis with Multicolor Flow Cytometry.
Adnan S, Farrukh S, Ahmed A, Shaikh M Int J Hematol Oncol Stem Cell Res. 2024; 18(4):400-402.
PMID: 39703470 PMC: 11652695. DOI: 10.18502/ijhoscr.v18i4.16764.
Paillassa J, Maitre E, Belarbi Boudjerra N, Madani A, Benlakhal R, Matthes T Cancers (Basel). 2024; 16(12).
PMID: 38927891 PMC: 11201647. DOI: 10.3390/cancers16122185.
Hairy cell leukemia - etiopathogenesis, diagnosis and modern therapeutic approach.
Mackowiak K, Jankowiak M, Szewczyk-Golec K, Holynska-Iwan I Biochem Med (Zagreb). 2024; 34(2):020502.
PMID: 38882583 PMC: 11177658. DOI: 10.11613/BM.2024.020502.
Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment.
Troussard X, Maitre E J Cell Mol Med. 2023; 28(3):e18060.
PMID: 38095234 PMC: 10844692. DOI: 10.1111/jcmm.18060.